/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Outcomes with oral anticoagulation resumption or discontinuation after an anticoagulation-related event in patients with atrial fibrillation
Event: ESC Congress 2023
Topic: Anticoagulants
Session: Oral anticoagulation: minimising bleeding
Non-vitamin K antagonist oral anticoagulants in complex clinical scenarios: from validation of cardiometabolic risk scores to use in the frail elderly patient
Event: ESC Congress 2023
Topic: Oral Anticoagulant Drugs
Session: Non-vitamin K antagonist oral anticoagulants in complex clinical scenarios: from validation of cardiometabolic risk scores to use in the frail elderly patient
Frailty and outcomes in octogenarians with atrial fibrillation treated with edoxaban: ESCAPE study
Event: ESC Congress 2022
Topic: Anticoagulants
Session: Challenges in cardiovascular pharmacotherapy in patients who are older or with comorbidities
Incidence of atrial fibrillation in an opportunistic screening campaign in a general practitioner setting: a prospective population study
Event: ESC Congress 2020
Topic: Prevalence and Incidence of Atrial Fibrillation
Session: Atrial Fibrillation ePosters
Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis
Event: ESC Congress 2019
Topic: Right Heart Catheterisation
Session: Interventional Cardiology
Real world persistence with direct oral anticoagulants in anticoagulation naive patients with atrial fibrillation
Event: ESC Congress 2019
Topic: Anticoagulants
Session: Perspectives on anticoagulation across cardiovascular disease
